Who makes Nifidipine?

Nifidipine is developed by Bayer.

What development phase is Nifidipine in?

Nifidipine is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Nifidipine

Bayer · FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	Nifidipine
Sponsor	Bayer
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study Evaluating the Efficacy of Nifedipine GITS - Telmisartan Combination in Blood Pressure Control. (PHASE4)
The Effect of LipoCol Forte® Capsules on the Pharmacokinetics of Nifedipine After Administering Single-dose Combination to Healthy Subjects (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Nifidipine CI brief — competitive landscape report
Nifidipine updates RSS · CI watch RSS
Bayer portfolio CI